港股异动|医疗保健股普涨健康中国行动稳步推进利好“大健康”行业
格隆汇7月25日丨医疗保健股普涨,其中先健科技(1302.HK)以7.195的涨幅领涨,中国先锋医药(1345.HK)涨近5%,阿里健康(0241.HK)涨超4%。国务院本月印发《国务院关于实施健康中国行动的意见》,意见指出,鼓励企业研发生产符合健康需求的产品,增加健康产品供给,国有企业特别是中央企业要作出表率。鼓励社会捐资,依托社会力量依法成立健康中国行动基金会,形成资金来源多元化的保障机制。鼓励金融机构创新健康类产品和服务。与此同时,国务院成立健康中国行动推进委员会,统筹推进《健康中国行动(2019—2030年)》组织实施、监测和考核相关工作。近期,健康中国行动推进委员会办公室已经举办多场举行新闻发布会,以促进《意见》的落地推进。分析人士认为,实施健康中国行动的意见将利好大健康行业的发展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.